Neuronal glutamate and GABAA receptor function in health and disease

Peter R. Moult

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Glutamate and GABA (γ-aminobutyric acid) are the predominant excitatory and inhibitory neurotransmitters in the mammalian CNS (central nervous system) respectively, and as such have undergone intense investigation. Given their predominance, it is no wonder that the reciprocal receptors for these neurotransmitters have attracted so much attention as potential targets for the promotion of health and the treatment of disease. Indeed, dysfunction of these receptors underlies a number of well-characterized neuropathological conditions such as anxiety, epilepsy and neurodegenerative diseases. Although intrinsically linked, the glutamatergic and GABAergic systems have, by and large, been investigated independently, with researchers falling into the ‘excitatory’ or ‘inhibitory’ camps. Around 70 delegates gathered at the University of St Andrews for this Biochemical Society Focused Meeting aimed at bringing excitation and inhibition together. With sessions on behaviour, receptor structure and function, receptor trafficking, activity-dependent changes in gene expression and excitation/inhibition in disease, the meeting was the ideal occasion for delegates from both backgrounds to interact. This issue of Biochemical Society Transactions contains papers written by those who gave oral presentations at the meeting. In this brief introductory review, I put into context and give a brief overview of these contributions.
Original languageEnglish
Pages (from-to)1317-1322
Number of pages6
JournalBiochemical Society Transactions
Volume37
Issue number6
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Glutamate Receptors
GABA-A Receptors
Health
Neurodegenerative diseases
Aminobutyrates
Neurotransmitter Receptor
Neurology
Health Promotion
Gene expression
Neurodegenerative Diseases
gamma-Aminobutyric Acid
Neurotransmitter Agents
Glutamic Acid
Epilepsy
Anxiety
Central Nervous System
Research Personnel
Gene Expression
Inhibition (Psychology)

Cite this

@article{fbb37a8833504214aa9452f5c598b22f,
title = "Neuronal glutamate and GABAA receptor function in health and disease",
abstract = "Glutamate and GABA (γ-aminobutyric acid) are the predominant excitatory and inhibitory neurotransmitters in the mammalian CNS (central nervous system) respectively, and as such have undergone intense investigation. Given their predominance, it is no wonder that the reciprocal receptors for these neurotransmitters have attracted so much attention as potential targets for the promotion of health and the treatment of disease. Indeed, dysfunction of these receptors underlies a number of well-characterized neuropathological conditions such as anxiety, epilepsy and neurodegenerative diseases. Although intrinsically linked, the glutamatergic and GABAergic systems have, by and large, been investigated independently, with researchers falling into the ‘excitatory’ or ‘inhibitory’ camps. Around 70 delegates gathered at the University of St Andrews for this Biochemical Society Focused Meeting aimed at bringing excitation and inhibition together. With sessions on behaviour, receptor structure and function, receptor trafficking, activity-dependent changes in gene expression and excitation/inhibition in disease, the meeting was the ideal occasion for delegates from both backgrounds to interact. This issue of Biochemical Society Transactions contains papers written by those who gave oral presentations at the meeting. In this brief introductory review, I put into context and give a brief overview of these contributions.",
author = "Moult, {Peter R.}",
year = "2009",
month = "12",
doi = "10.1042/BST0371317",
language = "English",
volume = "37",
pages = "1317--1322",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "6",

}

Neuronal glutamate and GABAA receptor function in health and disease. / Moult, Peter R.

In: Biochemical Society Transactions, Vol. 37, No. 6, 12.2009, p. 1317-1322.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Neuronal glutamate and GABAA receptor function in health and disease

AU - Moult, Peter R.

PY - 2009/12

Y1 - 2009/12

N2 - Glutamate and GABA (γ-aminobutyric acid) are the predominant excitatory and inhibitory neurotransmitters in the mammalian CNS (central nervous system) respectively, and as such have undergone intense investigation. Given their predominance, it is no wonder that the reciprocal receptors for these neurotransmitters have attracted so much attention as potential targets for the promotion of health and the treatment of disease. Indeed, dysfunction of these receptors underlies a number of well-characterized neuropathological conditions such as anxiety, epilepsy and neurodegenerative diseases. Although intrinsically linked, the glutamatergic and GABAergic systems have, by and large, been investigated independently, with researchers falling into the ‘excitatory’ or ‘inhibitory’ camps. Around 70 delegates gathered at the University of St Andrews for this Biochemical Society Focused Meeting aimed at bringing excitation and inhibition together. With sessions on behaviour, receptor structure and function, receptor trafficking, activity-dependent changes in gene expression and excitation/inhibition in disease, the meeting was the ideal occasion for delegates from both backgrounds to interact. This issue of Biochemical Society Transactions contains papers written by those who gave oral presentations at the meeting. In this brief introductory review, I put into context and give a brief overview of these contributions.

AB - Glutamate and GABA (γ-aminobutyric acid) are the predominant excitatory and inhibitory neurotransmitters in the mammalian CNS (central nervous system) respectively, and as such have undergone intense investigation. Given their predominance, it is no wonder that the reciprocal receptors for these neurotransmitters have attracted so much attention as potential targets for the promotion of health and the treatment of disease. Indeed, dysfunction of these receptors underlies a number of well-characterized neuropathological conditions such as anxiety, epilepsy and neurodegenerative diseases. Although intrinsically linked, the glutamatergic and GABAergic systems have, by and large, been investigated independently, with researchers falling into the ‘excitatory’ or ‘inhibitory’ camps. Around 70 delegates gathered at the University of St Andrews for this Biochemical Society Focused Meeting aimed at bringing excitation and inhibition together. With sessions on behaviour, receptor structure and function, receptor trafficking, activity-dependent changes in gene expression and excitation/inhibition in disease, the meeting was the ideal occasion for delegates from both backgrounds to interact. This issue of Biochemical Society Transactions contains papers written by those who gave oral presentations at the meeting. In this brief introductory review, I put into context and give a brief overview of these contributions.

U2 - 10.1042/BST0371317

DO - 10.1042/BST0371317

M3 - Article

VL - 37

SP - 1317

EP - 1322

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 6

ER -